Search

Partnerships with EUSA Pharma and Riemser Arzneimittel AG

caphosol

In 2009, Bendalis GmbH entered into partnership with EUSA Pharma, which has operations in the USA and Europe, for distribution of Caphosol®. Since the beginning of 2011, Bendalis GmbH has had a copromotion agreement with Riemser Arzneimittel AG for ALOXI® (palonosetron), an innovative 5-HT3 receptor antagonist for prophylaxis of chemotherapy-induced nausea and vomiting (CINV).